Sarepta launches $40M ATM

Sarepta Therapeutics Inc. (NASDAQ:SRPT) established an at-the-market program to sell up to $40 million of its common stock. Citadel Securities is the sales agent. Sarepta's eteplirsen is in Phase IIb ...